Загрузка...
Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
[Image: see text] Pancreatic cancer (PanCa) is a highly lethal disease with a poor 5 year survival rate, less than 7%. It has a dismal prognosis, and more than 50% of cases are detected at an advanced and metastatic stage. Gemcitabine (GEM) is a gold standard chemotherapy used for PanCa treatment. H...
Сохранить в:
| Опубликовано в: : | ACS Omega |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Chemical Society
2020
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178800/ https://ncbi.nlm.nih.gov/pubmed/32337462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c00793 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|